Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP853813.RAkCY2rTdMal9UnylkzLcypgYQZmsErl4yOq-hDXRN8Ig130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP853813.RAkCY2rTdMal9UnylkzLcypgYQZmsErl4yOq-hDXRN8Ig130_assertion type Assertion NP853813.RAkCY2rTdMal9UnylkzLcypgYQZmsErl4yOq-hDXRN8Ig130_head.
- NP853813.RAkCY2rTdMal9UnylkzLcypgYQZmsErl4yOq-hDXRN8Ig130_assertion wasGeneratedBy ECO_0000203 NP853813.RAkCY2rTdMal9UnylkzLcypgYQZmsErl4yOq-hDXRN8Ig130_provenance.
- NP853813.RAkCY2rTdMal9UnylkzLcypgYQZmsErl4yOq-hDXRN8Ig130_assertion wasDerivedFrom befree-20140225 NP853813.RAkCY2rTdMal9UnylkzLcypgYQZmsErl4yOq-hDXRN8Ig130_provenance.
- NP853813.RAkCY2rTdMal9UnylkzLcypgYQZmsErl4yOq-hDXRN8Ig130_assertion SIO_000772 23365634 NP853813.RAkCY2rTdMal9UnylkzLcypgYQZmsErl4yOq-hDXRN8Ig130_provenance.
- NP853813.RAkCY2rTdMal9UnylkzLcypgYQZmsErl4yOq-hDXRN8Ig130_assertion evidence source_evidence_literature NP853813.RAkCY2rTdMal9UnylkzLcypgYQZmsErl4yOq-hDXRN8Ig130_provenance.
- NP853813.RAkCY2rTdMal9UnylkzLcypgYQZmsErl4yOq-hDXRN8Ig130_assertion description "[Hydroxycamptothecin (HCPT) is a DNA topoisomerase I inhibitor, which has been utilized in chemotherapy for bladder cancer for nearly 40 years.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP853813.RAkCY2rTdMal9UnylkzLcypgYQZmsErl4yOq-hDXRN8Ig130_provenance.